Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 mai 2025 06h48 HE | Source: Research and Markets

Antibody Conjugate Oligonucleotide Market Analysis and Forecast, 2025-2035: CRISPR/Cas9 Integration with Oligonucleotide Conjugates Opens New Avenues in Gene Therapy

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Antibody Conjugate Oligonucleotide Market - A Global and Regional Analysis: Focus on Type, Oligonucleotide Type, Target Disease, and Country Analysis -...
24 mars 2025 10h13 HE | Source: Research and Markets

Antibody Drug Conjugate (ADC) Market Research 2024-2035: Currently, 47% of the ADCs are in Discovery / Preclinical Stages of Development

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target...
10 sept. 2024 12h36 HE | Source: Research and Markets

Degrader-Antibody Conjugates (DAC) Landscape Report 2024: Stakeholders, Platform Technologies, Development and Discovery Pipelines and Partnering Deals

Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective" report...